companies / resurrect-bio
Generated UTC · publication cutoff 2026-11-09
Insufficient cited evidence for a two-sentence summary.
verified=2026-06-14 json
| total_raised | 9,504,0009.5M | ○ |
|---|---|---|
| founded | 2021 | |
| hq | London, United Kingdom | |
| industry | unknown | |
| stage | series-a |
Resurrect Bio engineers disease-resistant crop traits using its FloraFold AI to identify the minimal genetic edits that restore the plant's own immune defenses. It serves agricultural and seed company partners targeting major pathogens across multiple crops. The team claims trait discovery roughly 5x faster than traditional breeding-based methods.
No cited completed company acquisition recorded.
Dated disclosures. Customer relationships and classifications are historical; ARR is separate from revenue.
No cited disclosure recorded: named customer, disclosed revenue, ARR, count, B2B / B2C, sector, go-to-market.
No cited valuation with an explicit basis is recorded.
Historical post-money / actual annual or stated TTM revenue. Same currency; economic valuation date within 90 days of revenue period end, inclusive. No FX, ARR, annualized revenue, estimates or projections. Conflicts and ambiguous ties are withheld.
No qualifying pair recorded.
| date | type | amount | lead | src |
|---|---|---|---|---|
| 2026-05-01 | series-a | 9,504,0009.5M | null | ○ |
@sentry/browser, afterpay, hsts, moment 0, parallax.js, react, sentry, spin.js, squarespace, squarespace commerce, stimulus, web-vitals
| fact | status | src |
|---|---|---|
| Series A, $9.5M | attributed | ○ |
| existence | self-reported | WEB |
| description | self-reported | WEB |